Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | 2 | HGF | 30.0 | 39 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 81.0 | 53 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 55.0 | 53 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 44.5 | 54 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 45.0 | 53 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 31.0 | 56 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 35.0 | 57 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 59.0 | 57 | |
RA2159 | TNF-a | 100 | ng/mL | 2 | HGF | 57.5 | 54 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 52.5 | 38 | |
N2645 | TNF-a | 100 | ng/mL | 2 | HGF | 47.0 | 55 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 40.0 | 45 | |
RA2708 | TNF-a | 100 | ng/mL | 2 | HGF | 32.5 | 32 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 103.0 | 58 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 74.0 | 51 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 83.0 | 49 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 69.0 | 51 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 52.0 | 60 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 48.0 | 53 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 92.0 | 50 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | HGF | 74.0 | 58 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 74.0 | 35 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | HGF | 66.0 | 53 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 63.0 | 57 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | HGF | 57.0 | 39 |